Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Huadao (Shanghai) Biopharmaceutical

Request full access

Cell immunotherapy technology developer for oncology treatments

Huangpu, ChinaFounded 2017

About Huadao (Shanghai) Biopharmaceutical

Huadao (Shanghai) Biopharmaceutical is a biotechnology company established in September 2017, focusing on developing cell immunotherapy technology for oncology. The company develops Chimeric Antigen Receptor T-cell (CAR-T) technologies, providing healthcare practitioners with resources and expertise to treat conditions like acute lymphoblastic leukemia.

Headquartered in Shanghai, China, Huadao Biopharma operates in the drug discovery and pharmaceuticals industry. It aims to create China's first fully-independent CAR-T industrial transformation and production technology platform with its own intellectual properties, under the motto "Affordable cell therapy for China's middle class." The company's technology portfolio includes bacteria fermentation engineering, virus purification techniques, and T-cell acquisition and harvesting. Its drug pipeline features candidates such as HD CD19 CAR-T, HD003, HD004, and HD006.

Huadao Biopharma is a privately held, venture capital-backed company. It has raised a total of $44.7M in funding. A significant Series B funding round in August 2019 raised $14.5M, with investors including Boai Nky Pharmaceuticals and Ren Dalong. The company received a CNY 100 million injection from NKY Medical Holdings Ltd in the same year. Other investors include New Horizon Capital, Oceanpine Capital, Huzhou Industrial Group, HY Energy Group, and Zhejiang United Investment Group.

Source: Dealroom company data

At a glance

Status
Operational
Open positions
None listed
Dealroom signal
11.7/100
Links
Website

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES D✓Equity / VC Feb 2024 — — Chongqing Ke Venture Capital · New Kaiyuan Pharmaceutical ↗
SERIES D✓Equity / VC Nov 2021 — — Sinowisdom · Zuig Investment —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Huadao (Shanghai) Biopharmaceutical website traffic

Latest recorded traffic for Huadao (Shanghai) Biopharmaceutical is 990 monthly website visits, down 61.9% over the last three months.

Latest monthly visits990 3-month web change-61.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Huadao (Shanghai) Biopharmaceutical in the Huangpu ecosystem

Live from Dealroom

The Huadao (Shanghai) Biopharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • NKY Medical Holdings

Series B and later4 investors entered at this stage

  • Sinowisdom
  • Zuig Investment
  • Chongqing Ke Venture Capital
  • New Kaiyuan Pharmaceutical
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Huangpu HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Huadao (Shanghai) Biopharmaceutical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Huadao (Shanghai) Biopharmaceutical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.